Slight nausea, temporary headache, fatigue, and injection site reactions represent the most frequently mentioned experiences
Choose peptide sets when you plan to evaluate two compounds side by side within the same assay run, allowing consistent sourcing, simpler ordering, and clearer comparisons across matched conditions
BPC-157 is not covered by insurance -- it's a cash-pay peptide therapy ($250/month at Moonshot Medical)
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
What are the storage and handling recommendations
For researchers new to peptide science, our peptide reconstitution guide provides step-by-step instructions for preparing research-grade compounds correctly
